Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

# Resources

Cholangiocarcinoma of the Liver – Symptoms, Treatment & Support

What Is Cholangiocarcinoma of the Liver? Cholangiocarcinoma, also known as bile duct cancer, is a rare and aggressive form of cancer that forms in the bile ducts. These ducts are thin tubes that carry digestive fluid bile from the liver to the gallbladder and the...

Renal Cell Carcinoma – Chromophobe – Symptoms, Treatment & Support

What Is Renal Cell Carcinoma – Chromophobe? Renal cell carcinoma – chromophobe (ChRCC) is a distinct subtype of renal cell carcinoma that accounts for approximately 5% of all kidney cancers. Characterized by cells that appear pale or clear under the...

Extra-Medullary Plasmacytoma of the Heart – Symptoms, Treatment & Support

What Is Extra-Medullary Plasmacytoma of the Heart? Extra-medullary plasmacytoma of the heart is a rare type of cancer that originates outside of the bone marrow in plasma cells, a type of white blood cell that produces antibodies. While plasmacytomas more commonly...

Hepatic Malignant Mixed Tumour – Symptoms, Treatment & Support

What Is Hepatic Malignant Mixed Tumour? Hepatic malignant mixed tumour is a rare type of liver cancer characterized by the presence of both epithelial and mesenchymal components. This means the tumour contains cells that are characteristic of both glandular tissues...

Nasopharyngeal Cancer, Undifferentiated – Symptoms, Treatment & Support

What Is Nasopharyngeal Cancer, Undifferentiated? Nasopharyngeal cancer, undifferentiated, refers to a type of cancer that arises in the nasopharynx, the upper part of the throat behind the nose. This cancer is characterized by cells that do not resemble normal cells...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter